By examining the association between CA-125 levels and ovarian lesion characteristics, including histological subtype, grade, and clinical stage, this study aimed to elucidate the diagnostic and prognostic implications of serum CA-125 levels in ovarian cancer management. This evidence concerns the gene MUC16 and ovarian cancer.